01 Enquiry system · Pharma
Qualified enquiry system for pharma manufacturers
For pharma manufacturers, the buying trigger is plant audits, tender cycles and new formulations. Enquiries come through trade directories, referrals and exhibitions; the problem is that technical enquiries are not routed to quality assurance, so the ones worth answering are not obvious.

Sector context
How Pharma buyers reach this point
Buying pharma services starts with plant audits, tender cycles and new formulations. Buyers are purchase heads at pharma manufacturers; the proof they ask for is GMP, certificate of analysis and audit history; and first contact usually comes through trade directories, referrals and exhibitions. The gap is what happens next: technical enquiries are not routed to quality assurance.
What this page is
A pattern from the sector and the build that answers it. No figure is published because none has been approved.
01 — Diagnosis
What was going wrong
For a pharma business, the pattern is familiar: plant audits, tender cycles and new formulations brings the enquiry, and technical enquiries are not routed to quality assurance.
- 01
Every pharma enquiry used the same form, so GMP and COA were unknown before the first call.
- 02
Plant audits, tender cycles and new formulations produced a spike, and the team could not tell a ready buyer from a price check.
- 03
No written definition of a qualified enquiry existed, so technical enquiries are not routed to quality assurance.
02 — Approach
Our approach
Every decision was tested against one question: does this make the next step clearer for the pharma buyer and the team?
- 01
A short qualification step captures GMP, COA and timeline before contact details.
- 02
Routing rules send each enquiry to the person who handles audit.
- 03
The client and we wrote down what qualified means for pharma manufacturers, then built the form to match.
- 04
Attribution from trade directories, referrals and exhibitions to the CRM record, so the source survives the handover.
03 — Publication standard
What this page does not show
- No dates and no figures. Where a performance number would normally sit for enquiry system work, this page has none because none has been approved for publication.
- What is checkable: the enquiry system problem scoped in section 01 and the build specified below. Both can be walked through on a call.
Cost
What ongoing work costs
Billed monthly. Website development sits outside these plans and is priced per year.
Same sector
More Pharma studies
03 Follow-up
Closing the enquiry follow-up gap for pharma manufacturers
In pharma, buyers are purchase heads at pharma manufacturers. Demand moves with plant audits, tender cycles and new formulations; first …
Read the study02 Local visibility
Local search visibility for pharma manufacturers
For pharma manufacturers, the buying trigger is plant audits, tender cycles and new formulations. Enquiries come through trade directories, …
Read the studyQuestions
Before you ask.
The questions Pharma buyers ask first — answered the way we would answer them on a call.
What does a qualified pharma enquiry look like?
How long does a enquiry system build take?
Do you work with our existing CRM?
Get started
Facing something similar?
A short consultation will tell you whether a comparable engagement makes sense for your business — and which part to fix first.
- A written recommendation, not a sales deck
- Scope, sequence and cost before anything starts
- We say no when the work is not worth your money
Request a consultation
Two minutes now saves a discovery call later.